In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Tevogen Bio Holdings Inc (NASDAQ: TVGN) closed at $1.24 down -2.36% from its previous closing price of $1.27. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 0.56 million shares were traded.
Ratios:
For a deeper understanding of Tevogen Bio Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.35 and its Current Ratio is at 0.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on March 04, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 09 ’25 when Saadi Ryan H. sold 1,438,206 shares for $1.23 per share. The transaction valued at 1,768,993 led to the insider holds 116,814,453 shares of the business.
Saadi Ryan H. bought 1,438,206 shares of TVGN for $1,582,027 on Jun 09 ’25. On Mar 12 ’25, another insider, Flomenberg Neal, who serves as the insider of the company, sold 232,968 shares for $1.09 each. As a result, the insider received 253,935 and left with 3,595,608 shares of the company.
Stock Price History:
Over the past 52 weeks, TVGN has reached a high of $3.09, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 9.91%, while the 200-Day Moving Average is calculated to be 7.03%.
Shares Statistics:
A total of 183.89M shares are outstanding, with a floating share count of 28.38M. Insiders hold about 84.56% of the company’s shares, while institutions hold 2.10% stake in the company.